Combinatorial pathway engineering for optimized production of the anti‐malarial FR900098

As resistance to current anti‐malarial therapeutics spreads, new compounds to treat malaria are increasingly needed. One promising compound is FR900098, a naturally occurring phosphonate. Due to limitations in both chemical synthesis and biosynthetic methods for FR900098 production, this potential therapeutic has yet to see widespread implementation. Here we applied a combinatorial pathway engineering strategy to improve the production of FR900098 in Escherichia coli by modulating each of the pathway's nine genes with four promoters of different strengths. Due to the large size of the library and the low screening throughput, it was necessary to develop a novel screening strategy that significantly reduced the sample size needed to find an optimal strain. This was done by using biased libraries that localize searching around top hits and home in on high‐producing strains. By incorporating this strategy, a significantly improved strain was found after screening less than 3% of the entire library. When coupled with culturing optimization, a strain was found to produce 96 mg/L, a 16‐fold improvement over the original strain. We believe the enriched library method developed here can be used on other large pathways that may be difficult to engineer by combinatorial methods due to low screening throughput. Biotechnol. Bioeng. 2016;113: 384–392. © 2015 Wiley Periodicals, Inc.

[1]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[2]  M. Okuhara,et al.  Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization. , 1980, The Journal of antibiotics.

[3]  M. Okuhara,et al.  STUDIES ON NEW PHOSPHONIC ACID ANTIBIOTICS , 1980 .

[4]  J. Knowles,et al.  Phosphonate biosynthesis: isolation of the enzyme responsible for the formation of a carbon–phosphorus bond , 1988, Nature.

[5]  D. Dunaway-Mariano,et al.  Catalysis and thermodynamics of the phosphoenolpyruvate/phosphonopyruvate rearrangement. Entry into the phosphonate class of naturally occurring organophosphorus compounds , 1988 .

[6]  B. Wanner,et al.  Molecular genetic studies of a 10.9-kb operon in Escherichia coli for phosphonate uptake and biodegradation. , 1992, FEMS microbiology letters.

[7]  F. Arnold,et al.  Directed evolution of enzyme catalysts. , 1997, Trends in biotechnology.

[8]  H. Lichtenthaler,et al.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.

[9]  A. Bacher,et al.  Biosynthesis of isoprenoids via the non-mevalonate pathway , 2004, Cellular and Molecular Life Sciences CMLS.

[10]  M. Schlitzer,et al.  A Novel Short and Efficient Synthetic Route to the Antimalarial Agent FR900098 and Derivatives , 2007 .

[11]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance. , 2007, The American journal of tropical medicine and hygiene.

[12]  A. A. Fokin,et al.  Synthesis of the antimalarial drug FR900098 utilizing the nitroso-ene reaction. , 2007, Organic letters.

[13]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.

[14]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase. , 2007, The American journal of tropical medicine and hygiene.

[15]  N. Kelleher,et al.  Cloning, expression, and biochemical characterization of Streptomyces rubellomurinus genes required for biosynthesis of antimalarial compound FR900098. , 2008, Chemistry & biology.

[16]  Tyler W Johannes.  Directed evolution of phosphite dehydrogenase and engineered biosynthesis of FR-900098 , 2008 .

[17]  Zengyi Shao,et al.  DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways , 2008, Nucleic acids research.

[18]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[19]  Carola Engler,et al.  Golden Gate Shuffling: A One-Pot DNA Shuffling Method Based on Type IIs Restriction Enzymes , 2009, PloS one.

[20]  W. Metcalf,et al.  Biosynthesis of phosphonic and phosphinic acid natural products. , 2009, Annual review of biochemistry.

[21]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[22]  N. Kelleher,et al.  Deciphering the late biosynthetic steps of antimalarial compound FR-900098. , 2010, Chemistry & biology.

[23]  Y. Kitade,et al.  Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum , 2011, Scientific reports.

[24]  Huimin Zhao,et al.  New N-Acetyltransferase Fold in the Structure and Mechanism of the Phosphonate Biosynthetic Enzyme FrbF* , 2011, The Journal of Biological Chemistry.

[25]  T. Wellems,et al.  The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.

[26]  Huimin Zhao,et al.  Combinatorial Design of a Highly Efficient Xylose-Utilizing Pathway in Saccharomyces cerevisiae for the Production of Cellulosic Biofuels , 2012, Applied and Environmental Microbiology.

[27]  Thomas H. Segall-Shapiro,et al.  Modular control of multiple pathways using engineered orthogonal T7 polymerases , 2012, Nucleic acids research.

[28]  Huimin Zhao,et al.  Customized optimization of metabolic pathways by combinatorial transcriptional engineering , 2012, Nucleic acids research.

[29]  Meng Wang,et al.  Biocatalyst development by directed evolution. , 2012, Bioresource technology.

[30]  Jingwen Zhou,et al.  Metabolic engineering of Escherichia coli for (2S)-pinocembrin production from glucose by a modular metabolic strategy. , 2013, Metabolic engineering.

[31]  J. Keasling,et al.  Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly , 2014, Applied Microbiology and Biotechnology.

[32]  M. Larhed,et al.  Synthesis of antimalarial compounds fosmidomycin and FR900098 through N- or P-alkylation reactions , 2013 .

[33]  Jian Chen,et al.  Multivariate modular metabolic engineering of Escherichia coli to produce resveratrol from L-tyrosine. , 2013, Journal of biotechnology.

[34]  C. Tomlin,et al.  Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay , 2013, Nucleic acids research.

[35]  Luke N. Latimer,et al.  Employing a combinatorial expression approach to characterize xylose utilization in Saccharomyces cerevisiae. , 2014, Metabolic engineering.

[36]  R. Cibulskis,et al.  World Malaria Report 2013 , 2014 .

[37]  Swapnil Bhatia,et al.  Functional optimization of gene clusters by combinatorial design and assembly , 2014, Nature Biotechnology.

[38]  H. Salis,et al.  Efficient search, mapping, and optimization of multi‐protein genetic systems in diverse bacteria , 2014 .

[39]  Huimin Zhao,et al.  Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor. , 2015, Chemical communications.